Evidence map›Paper›PMID 40723861›Full record

ArticleBiomolecules2025

Discovery of a Potent Antimicrobial Peptide Through Rational Design: A New Frontier in Pathogen Control.

Bruna Agrillo, Monica Ambrosio, Rosa Luisa Ambrosio, Marta Gogliettino, Marco Balestrieri, Alessandra Porritiello, Maria Francesca Peruzy, Andrea Mancusi, Luigi Nicolais, Gianna Palmieri

Abstract read
In one paragraph

Article in Biomolecules, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Bruna AgrilloInstitute of Biosciences and BioResources, National Research Council (IBBR-CNR), 80131 Naples, Italy.
Monica AmbrosioInstitute of Biosciences and BioResources, National Research Council (IBBR-CNR), 80131 Naples, Italy.ORCID 0000-0001-5061-4420
Rosa Luisa AmbrosioDepartment of Veterinary Medicine and Animal Production, University of Naples Federico II, 80137 Naples, Italy.ORCID 0000-0002-4413-142X
Marta GogliettinoInstitute of Biosciences and BioResources, National Research Council (IBBR-CNR), 80131 Naples, Italy.
Marco BalestrieriInstitute of Biosciences and BioResources, National Research Council (IBBR-CNR), 80131 Naples, Italy.
Alessandra PorritielloInstitute of Biosciences and BioResources, National Research Council (IBBR-CNR), 80131 Naples, Italy.
Maria Francesca PeruzyDepartment of Veterinary Medicine and Animal Production, University of Naples Federico II, 80137 Naples, Italy.ORCID 0000-0002-9148-3671
Andrea MancusiDepartment of Food Microbiology, Istituto Zooprofilattico Sperimentale del Mezzogiorno, 80055 Portici, Italy.ORCID 0000-0002-7069-3274
Luigi NicolaisMaterias Srl, 80146 Naples, Italy.ORCID 0000-0001-6517-6611
Gianna PalmieriInstitute of Biosciences and BioResources, National Research Council (IBBR-CNR), 80131 Naples, Italy.

Funding

Ministero delle Imprese e del Made in Italy-Fondo per la Crescita Sostenibile-Accordi per l'innovazione TEcnoLogie innovative di bioeconomia circoLare per l'Uso nel Settore agrifood (TELLUS) F/310066/02/X56Ministero dell'Università e della Ricerca- CNR project NUTRAGE FOE-2021 DBA.AD005.225Ministero dell'Università e della Ricerca- project PNRR-PE00000003, PE10-Modelli per un'alimentazione sostenibile project PNRR-PE00000003, PE10 ON Foods
6 · The paper itself

Abstract

The increasing circulation of multi-drug-resistant pathogens, coupled with the sluggish development of new antibiotics, is weakening our capacity to combat human infections, resulting in elevated death tolls. To address this worldwide crisis, antimicrobial peptides (AMPs) are viewed as promising substitutes or adjuvants for combating bacterial infections caused by multidrug-resistant organisms. Here, the antimicrobial activity and structural characterization of a novel 13-amino acid cationic peptide named RKW (RKWILKWLRTWKK-NH2), designed based on known AMPs sequences and the identification of a key tryptophan-rich structural motif, were described. RKW displayed a broad-spectrum and potent antimicrobial and antibiofilm activity against Gram-positive and Gram-negative pathogens, including ESKAPE bacteria and fungi with minimal inhibitory concentrations (MBC) ranging from 5 µM to 20 μM. Structural results by fluorescence and Circular Dichroism (CD) spectroscopy revealed that the peptide was folded into a regular α-helical conformation in a membrane-like environment, remaining stable in a wide range of pH and temperature for at least 48 h of incubation. Furthermore, RKW showed low toxicity in vitro against mammalian fibroblast cells, indicating its potential as a promising candidate for the development of new antimicrobial or antiseptic strategies.

Indexed as

Anti-Bacterial AgentsAntimicrobial Cationic PeptidesAntimicrobial PeptidesDrug DesignAmino Acid SequenceAnimalsBiofilmsCircular DichroismFungiGram-Negative BacteriaGram-Positive BacteriaHumansMicrobial Sensitivity TestsAnti-Bacterial AgentsAntimicrobial Cationic PeptidesAntimicrobial Peptidesantibiofilm activityantimicrobial activityantimicrobial resistancecationic antimicrobial peptideESKAPE pathogenspeptide design

Identifiers

PMID40723861
PMCPMC12292521

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.